Probert, Christopher S J <br/><br/>
Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.  [electronic resource] 

 -  Journal of Crohn's & colitis  Mar 2014 
 - 200-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-4479 
<br/><br/><label>Standard No.: </label>10.1016/j.crohns.2013.08.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Administration, Rectal<br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Colitis, Ulcerative--complications<br/>Colonoscopy<br/>Double-Blind Method<br/>Enema<br/>Female<br/>Gastrointestinal Hemorrhage--drug therapy<br/>Humans<br/>Intestinal Mucosa--physiopathology<br/>Male<br/>Mesalamine--administration & dosage<br/>Quality of Life<br/>Rectal Diseases--drug therapy<br/>Severity of Illness Index<br/>Time Factors<br/>Wound Healing--drug effects<br/>Young Adult